References
- Queenan JT. Erythroblastosis fetalis: closing the circle. N Engl J Med 1986;314:1448–9.
- Bourgeois L. Observations Diverse sur la Sterilite Perte de Fruiot, Foecondite, Accouchments, et Maladies de Femmes, et Enfants Nouveaux-naiz, Paris, 1609.
- Rautmann H. Ueber blutbildung bei fotaler allgemeiner wassersuch. Beit Z Path Anat u z allg Path 1912;54:332.
- Buhrman WL, Sanford HN. Is familial jaundice of newborn infants erythroblastosis fetalis? Am J Dis Child 1931;41:225-35.
- Landsteiner K,Wiener AJ.An agglutinable factor in human blood recognized by immune sera for rhesus blood. Proc Soc Exp Biol Med 1940;43: 223-4.
- Levine P, Burnham L, Katzin EM, et al.The role of isoimmunization in the pathogenesis of erythroblastosis fetalis. Am J Obstet Gynecol 1941;42: 825-7.
- Bowman J. Thirty-five years of Rh prophylaxis. Transfusion 2003;43:1661–6.
- Kumpel BM.Transfusion 2006;46:1652-6.
- Hadley AG. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.Transpl Immunol 2002;10:191–8.
- Said S, McParland P. Update on the management of non anti-D antibodies. Ir Med J 2006;99:55–6.
- Detti L,Akiyama M, Mari G. Doppler blood flow in obstetrics. Curr Opin Obstet Gynecol 2002;14: 587–93.
- Geifman-Holtzman O, Bernstein IM, Berry SM, et al. Fetal RhD genotyping in fetal cells flow sorted from maternal blood. Am J Obstet Gynecol 1996; 174:818–22.
- Geifman-Holtzman O, Grotegus CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood: a meta-analysis.Am J Obstet Gynecol 2006;195:1163–73.
- Bowman JM. Hemolytic disease (erythroblastosis fetalis). In: Creasy R, Resnik R, eds. Maternal-fetal medicine, 4th ed. Philadelphia:WB Saunders, 1999: 736–67.
- Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization.Am J Obstet Gynecol 1961;82:1359–70.
- Queenan JT,Tomai TP, Ural SH, et al. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14–40 weeks’ gestation: a proposal for clinical management.Am J Obstet Gynecol 1993:168: 1370–6.
- Faas BH, Maaskant-Van Wijk PA, von dem Borne AE, et al. The applicability of different PCR-based methods for fetal RHD and K1 genotyping: a prospective study. Prenat Diagn 2000;20:453–8.
- Dukler D, Oepkes D, Seaward G, Windrim R. Noninvasive tests to predict fetal anemia: a study comparing Doppler and ultrasound parameters. Am J Obstet Gynecol 2003;188:1310–4.
- Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342:9–14.
- Zimmerman R, Carpenter RJ Jr, Durig P, et al. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat. Br J Obstet Gynaecol 2002;109: 746–52.
- Oepkes D,Seaward PG,Vandenbussche FP,et al.The Diamond Study Group. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006;355:156–64.
- Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J 1963;5365:1107–9.
- Nicolaides KH, Soothill PW, Rodech CH, et al. Rh disease: intravascular fetal blood transfusion by cordocentesis. Fetal Ther 1986;1:185–92.
- Van Kamp IL, Klumper FJ, Bakkum RS, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red cell alloimmunization.Am J Obstet Gynecol 2005;192: 171–7.